Livzon News_Livzon Pharmaceutical Group Inc.

News Center

New Lijuzhu Magazine

The LIZHU brand ranks 318th in the top 500 brand values.

On December 18, 2017, the China Brand Value 500 Strong Review Committee announced the 11th China Brand Value 500 Strong List for 2017. Lijuzhu Group ranked 318th in the China Brand Value 500 Strong.

2017-12-20

Double report and double approval, congratulations!

Double report and double approval, congratulations!

Recently, Zhuhai Lizhu Monoclonal Antibody Biotechnology Co., Ltd., a subsidiary of Lizhu Pharmaceutical Group Co., Ltd., received the "Drug Clinical Trial Approval" issued by the National Medical Products Administration (Approval No.: 2017L04883).  1. Main content of the drug approval Drug name: Recombinant Humanized Anti-PD-1 Monoclonal Antibody for Injection English name/Latin name: Recombinant Humanized anti-PD-1 Monoclonal Antibody for Injection Dosage form: Injection Specification: 50mg/

2017-11-06

Lijuzhankang Company PD-1 monoclonal antibody has successfully obtained clinical approval from the US FDA.

Lijuzhankang Company PD-1 monoclonal antibody has successfully obtained clinical approval from the US FDA.

On July 28, local time in the United States, the FDA officially issued a letter approving the clinical trial application for the injectable recombinant humanized anti-PD-1 monoclonal antibody (code: LZM009) from Zhuhai Lizhu Biotech Co., Ltd. Lizhu Biotech formally submitted the clinical application to the FDA on June 29. During the review, there were no additional requests for information regarding Lizhu's materials, and on July 28 (the 30th day), the clinical trial was successfully approved, with plans to start clinical research in the United States in August. The successful approval of LZM009 for clinical trials in the United States is a significant step for Lizhu towards internationalization. Since its establishment, Lizhu Biotech has accumulated a wealth of innovative drug R&D pipelines.

2017-08-01

The Deputy Director of the National Development and Reform Commission visited Lizhu for research.

The Deputy Director of the National Development and Reform Commission visited Lizhu for research.

To promote the accelerated development of the biopharmaceutical industry and support strong pharmaceutical companies to grow larger and stronger, this morning, Shen Zhulin, Deputy Director of the High-Tech Industry Department of the National Development and Reform Commission, visited the Lizhu Industrial Park for an on-site investigation to understand the development situation of the enterprise. Tao Desheng, President of Lizhu Group, and Zhou Peng, Vice President, accompanied Deputy Director Shen to visit the intelligent logistics system of Lizhu Industrial Park and introduced the development overview of Lizhu in the exhibition hall. In the intelligent elevated warehouse of Lizhu Industrial Park, unmanned AGV carts shuttle back and forth, accurately storing finished products in an orderly manner. President Tao introduced this intelligent logistics system to Deputy Director Shen while touring, which uses all imported equipment and has achieved unmanned operation.

2017-07-06

Charity knows no borders. Zhu Baoguo, a council member, has been awarded the TNC Oak Leaf Award.

Charity knows no borders. Zhu Baoguo, a council member, has been awarded the TNC Oak Leaf Award.

On the evening of June 21, 2017, Eastern Time, at the "2017 Global Volunteer Leaders Summit" held by The Nature Conservancy (TNC) in Washington, D.C., Director Zhu Baoguo was awarded TNC's highest honor - the "Oak Leaf Award". Mr. Mark Tercek, the global president of TNC, personally presented the medal to him. This award reaffirms Director Zhu Baoguo's significant contributions to the cause of nature conservation and the outstanding leadership he has demonstrated throughout the process.    The award committee highly praised Director Zhu Baoguo's commitment to nature conservation: "Zhu Bao..."

2017-06-22

China Brand Day Lijuzhu is on the way

May 10, 2017, China Brand Day. You must not be unaware of this day.

2017-05-07

Healthy China, Go Lijuzhu

Healthy China, Go Lijuzhu

On the morning of the 15th, the two-day China Hospital Directors Forum grandly opened in the beautiful Zhuhai. The selected themes of the forum are all highlights: "The direction of comprehensive reform of public hospitals," directly addressing the "Healthy China 2030" national strategy; "Progress in the construction of hospital quality management standard platforms," providing a path for the standardized development of the industry; "How to be a good director of a public hospital under the modern hospital management system," directly facing the management challenges of public hospitals; "The concept and practice of creating specialized alliances," exploring new directions for medical reform; "The current situation and future of precision medicine at home and abroad," becoming an inevitable path for the development of medicine to align with international standards.

2017-04-14

Cao Hui: Strengthen Collaborative Cooperation to Promote Innovation in Traditional Chinese Medicine

Cao Hui: Strengthen Collaborative Cooperation to Promote Innovation in Traditional Chinese Medicine

Traditional Chinese medicine is an important part of the outstanding historical culture and modern civilization of the Chinese nation, and it serves as the material foundation of our country's traditional Chinese medicine system for disease prevention and treatment. After thousands of years of clinical practice, its unique effects in disease prevention and treatment, along with relatively low toxicity and side effects, have gained recognition from the global medical community. The research and development of the traditional Chinese medicine industry is gradually becoming an international hotspot. The engineering technology and standardization research of modern traditional Chinese medicine quality control, as one of the key technologies for the modernization and internationalization of traditional Chinese medicine, focuses on demonstrative research of quality evaluation technologies for representative traditional Chinese medicine raw materials, intermediates, and finished products throughout the entire process, making it a hot topic of research both domestically and internationally. Professor Cao Hui 1983

2017-03-12

< 1...9 10 11...22 > proceed page

Address: No.38, Chuangye North Road, Jinwan District, Zhuhai, Guangdong, P.R.China

京ICP备10002622号

Website :www.300.cn SEO [ Privacy Policy ]

Internet Drug Information Service Qualification Certificate: Guangdong-Non-Operating -2020-0186

Drug Business License: Guangdong AA7560155

Business License

Home | E-mail | Legal Statement

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.